Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Clinical Study Results

  • FLOMAX ® - Urination Disorders
    Clinical Study Number 527.49
    Study Indication Urination Disorders
    Product FLOMAX ®
    Generic Name Tamsulosin
    Lab Code
    Clinical Phase I
    Study Title

    Pharmacokinetics, safety, and tolerability of single oral doses (0.1, 0.2, 0.4 and 0.8 mg) of tamsulosin hydrochloride in children with voiding disorders

    Study Document
    Trial synopsis 527.49 english
  • FLOMAX ® - Urination Disorders
    Clinical Study Number 527.85
    Study Indication Urination Disorders
    Product FLOMAX ®
    Generic Name Tamsulosin
    Lab Code
    Clinical Phase III
    Study Title

    A 6-month OTC-simulated, open label, uncontrolled study of tamsulosin 0.4 mg in men

    Study Document
    Trial synopsis 527.85 english